Shining a light on IgA nephropathy (IgAN)

https://rarerevolutionmagazine.com/digitalspotlight/shining-a-light-on-iga-nephropathy-igan/ Chee Kay Cheung is a consultant nephrologist and honorary associate professor at University Hospitals of Leicester. His research focuses on glomerular diseases, especially IgAN. Here he provides his expert insights into some of the most frequently asked questions around IgAN This article has been sponsored by CSL Vifor and is drawn from a Q&A session which was organised and funded by CSL Vifor. IgAN, previously known as Berger’s disease, is a rare immune-mediated disease and the most common type of glomerular disease—a condition that affects the kidney’s filters, known as glomeruli.1–4 What sets IgAN apart is the buildup of a specific antibody called immunoglobulin A subtype 1 (IgA1) in these filters, leading to inflammation and potential kidney damage over time.2